Picture ConsulTech GmbH Forschungszulage 650x80px

Document › Details

Celyad S.A.. (3/28/19). "Press Release: Celyad Reports Business Update and Full Year 2018 Financial and Operating Results". Mont-Saint-Guibert.

	Organisation	Celyad S.A. (Euronext Brussels + Paris: CYAD, Nasdaq: CYAD)
	Group	Celyad (Group)
	Organisation 2	Mesoblast Ltd. (ASX: MSB, Nasdaq: MESO)
	Product	shRNA technology
	Product 2	CYAD-01 (CAR-T NKG2D) CAR-T cell therapy
	Person	Homsy, Christian (Celyad 201904– Non-executive Board Director before CEO of Celyad / Cardio3 BioSciences since 2007)
	Person 2	Zelkovic, Sara (LifeSci 201810 LifeSci Public Relations)

Original document
accessed by [iito] on 2019-04-01

Record changed: 2019-04-06

More documents for Celyad (Group)

[1] Hyloris Pharmaceuticals S.A.. (5/26/20). "Press Release: Hyloris Appoints Patrick Jeanmart as Chief Financial Officer". Liège....
[2] Celyad S.A.. (9/16/19). "Press Release: Celyad Announces Closing of $20 Million Global Offering". Mont-Saint-Guibert....
[3] Celyad S.A.. (4/1/19). "Press Release: Celyad Announces April 2019 Investor Conference Schedule". Mont-Saint-Guibert....
[4] Celyad S.A.. (3/28/19). "Press Release: Celyad Appoints Filippo Petti as Chief Executive Officer. Dr Christian Homsy Continues as Non-executive Director and Chair of the Strategy Committee of the Board of Directors". Mont-Saint-Guibert....
[5] Celyad S.A.. (3/18/19). "Press Release: Celyad’s 2019 R&D Day Highlights shRNA Platform and Pipeline of Next-generation NKG2D-based and Off-the-Shelf Non-gene Edited CAR-T Candidates". Mont-Saint-Guibert....
[6] Celyad S.A.. (3/8/19). "Press Release: Celyad Appoints Anne Moore as Vice President Corporate Strategy". Mont-Saint-Guibert....
[7] Celyad S.A.. (11/21/18). "Press Release: Celyad Announces Third Quarter 2018 Business Update". Mont-Saint-Guibert....
[8] Celyad S.A.. (11/15/18). "Press Release: Celyad to Participate at Upcoming Healthcare Conferences". Mont-Saint-Guibert....
[9] Celyad S.A.. (10/4/18). "Press Release: Celyad Announces Exclusive Agreement for Horizon Discovery’s shRNA Platform to Develop NextGeneration Allogeneic CAR-T Therapies". Mont-Saint-Guibert....
[10] Celyad S.A.. (9/26/18). "Press Release: Celyad Appoints Carri Duncan as Vice-President Corporate Development and Communications". Mont-Saint-Guibert....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]